Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques
The cellular immune response of seven rhesus macaques immunized with Tween-ether-treated macaque strain of simian immunodeficiency virus (SIVMAC) and three non-vaccinated control animals was investigated. Immunization elicited antigen-specific proliferating CD4+ cells in five of seven monkeys. Proliferating T cells were found in all animals protected from a first virus challenge. Cytotoxic T lymphocytes (CTLs) were not induced by the immunization. After the second challenge, the four formerly protected animals became infected, despite a strong proliferative CD4+ cell activity in three of them. All animals lost their proliferative activity 2 weeks after infection. After the first challenge four of the six infected animals exhibited a CTL response and after the second challenge, one of four newly infected macaques acquired a CTL response. The five animals with a CTL activity against SIVMAC proteins were protected from severe thrombo-cytopenia, which appeared in the five CTL-negative animals after infection. Our data show the induction of proliferative T cells by immunization with soluble SIVMAC antigen. This T cell reactivity was found in all animals protected from the first virus challenge, but did not confer protection from the second challenge. Interestingly, the proliferative T cell reactivity disappeared 2 weeks after virus infection. Furthermore a CTL response against viral proteins seems to protect infected animals from severe thrombocytopenia which is an early sign of AIDS in monkeys.
AchourA.,
PicardO.,
ZaguryD.,
SarinP. S.,
GalloR. C.,
NaylorP. H.,
GoldsteinA. L.1990; HGP30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proceedings of the National Academy of Sciences U.S.A. 87:7045–7049
AhearneP. M.,
MatthewsT. J.,
LyerlyH. K.,
WhiteG. C.,
BolognesiD. P.,
WeinholdK. J.1988; Cellular immune response to viral peptides in patients exposed to HIV. AIDS Research and Human Retroviruses 4:259–267
Ahmed-AnsariA.,
PowellJ. D.,
JensenP. E.,
Yehuda-CohenT.,
McClureH. M.,
AndersonD.,
FultzP. N.,
SellK. W.1990; Requirements for simian immunodeficiency virus antigen-specific in vitro proliferation of T cells from infected rhesus macaques and sooty mangabeys. AIDS 4:399–407
BerzofskyJ. A.,
BensussanA.,
CeaseK. B.,
BourgeJ. F.,
CheynierR.,
LurhumaZ.,
SalaünJ.-J.,
GalloR. C.,
ShearerG. M.,
ZaguryD.1988; Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature, London 334:706–708
CarlsonJ. R.,
McGrawT. P.,
KeddieE.,
YeeJ. L.,
RosenthalA.,
LangloisA. J.,
DickoverR.,
DonovanR.,
LuciwP. A.,
JenningsM. B.,
GardnerM. B.1990; Vaccine protection of rhesus macques against simian immunodeficiency virus infection. AIDS Research and Human Retroviruses 6:1239–1246
ChencinerN.,
MichelF.,
DadaglioG.,
Langlade-DemoyenP.,
HoffenbachA.,
LerouxA.,
Garcia-PonsF.,
RautmannG.,
GuyB.,
GuillonJ.-M.,
MayaudC.,
GirardM.,
AutranB.,
KienyM.-P.,
PlataF.1989; Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. European Journal of Immunology 19:1537–1544
ClericiM.,
LuceyD. R.,
ZajacR. A.,
BoswellR. N.,
GebelH. M.,
TakahashiH.,
BerzofskyJ. A.,
ShearerG. M.1991; Detection of cytotoxic T lymphocytes specific for synthetic peptides of gpl60 in HIV-seropositive individuals. Journal of Immunology 146:2214–2219
CranageM. P.,
CookN.,
JohnstoneP.,
GreenawayP. J.,
KitchinP. A.,
StottE. J.,
AlmondN.,
BaskervilleA.1990; SIV infection of rhesus macaques: in vitro titration of infectivity and development of an experimental vaccine. In Animal Models in AIDS pp 103–114 Edited by
SchellekensH.,
HorzinekM. C.
Amsterdam: Elsevier;
CulmannB.,
GomardE.,
KienyM.-P.,
GuyB.,
DreyfusF.,
SaimotA.-G.,
SeriniD.,
SicardD.,
LevyJ.-P.1991; Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV1 nef protein. Journal of Immunology 146:1560–1565
DanielM. D.,
LetvinN. L.,
KingN. W.,
KannagiM.,
SehgalP. K.,
HuntR. D.,
KankiP. J.,
EssexM. F.,
DesrosiersR. C.1985; Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201–1204
DesrosiersR. C.,
WyandM. S.,
KodamaT.,
RinglerD. J.,
ArthurL. O.,
SehgalP. K.,
LetvinN. L.,
KingN. W.,
DanielM. D.1989; Vaccine protection against simian immunodeficiency virus infection. Proceedings of the National Academy of Sciences U.S.A. 86:6353–6357
EarlP. L.,
KoenigS.,
MossB.1991; Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. Journal of Virology 65:31–41
EichbergJ. W.,
ZarlingJ. M.,
AlterH. J.,
LevyJ. A.,
BermanP. W.,
GregoryT.,
LaskyL. A.,
McClureJ.,
CobbK. E.,
MoranP. A.,
HuS.-L.,
KennedyR. C.,
ChanhT. C.,
DreesmanG. R.1987; T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. Journal of Virology 61:3804–3808
GotchF. M.,
KellyC.,
EllisS. A.,
WallaceL.,
RickinsonA. B.,
van der PoelJ.,
CrumptonM. J.,
McmichaelA. J.1985; Characterization of the HLA A2.2 subtype. T cell evidence for further heterogeneity. Immunogenetics 21:11–23
GotchF. M.,
NixonD. F.,
AlpN.,
McMichaelA.,
BorysiewiczL. K.1990; High frequency of memory and effector gag-specific cytotoxic T lymphocytes in HIV-seropositive individual. International Immunology 2:707–712
GotchF. M.,
HovellR.,
DelchambreM.,
SilveraP.,
McMichaelM.1991; Cytotoxic T cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS 5:317–320
GrabsteinK.,
ChenY. U.1980; Cell-mediated cytolytic responses. In Selected Methods in Cellular Immunology pp 128137 Edited by
MishellB. B.,
ShiigiS. M.
San Francisco: Freeman;
HammondS. A.,
ObahE.,
StanhopeP.,
MonellC. R.,
StrandM.,
RobbinsF. M.,
BiasW. B.,
KarrR. W.,
KoenigS.,
SilicianoR. F.1991; Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccineinduced human cytolytic T cells. Journal of Immunology 146:1470–1477
HoffenbachA.,
Landlade-DemoyenP.,
DadaglioG.,
VilmerD.,
MichelF.,
MayaudC.,
AutranB.,
PlataF.1989; Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. Journal of Immunology 142:452–462
HosmalinA.,
ClericiM.,
HoughtenR.,
PendletonC. D.,
FlexnerC.,
LuceyD. R.,
MossB.,
GermainR. N.,
ShearerG. M.,
BerzofskyJ. A.1990; An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences U.S.A. 87:2344–2348
HuS.-L,
AbramsK.,
BarberG. N.,
MoranP.,
ZarlingJ. M.,
LangloisA. J.,
KullerL.,
MortonW. R.,
BenvenisteR. E.1992; Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 255:456–459
KannagiM.,
ChalifouxL. V.,
LordC. I.,
LetvinN. L.1988; Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. Journal of Immunology 140:2237–2242
KannagiM.,
MasudaT.,
HattoriT.,
KanohT.,
NasuK.,
YamamotoN.,
HaradaS.1990; Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. Journal of Virology 64:3399–3406
KoenigS.,
EarlP.,
PowellD.,
PantaleoG.,
MerliS.,
MossB.,
FauciA. S.1988; Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-l-infected individual. Proceedings of the National Academy of Sciences, U.S.A. 85:8638–8642
KoenigS.,
FuerstT. R.,
WoodL. V.,
WoodsR. M.,
SuzichJ. A.,
JonesG. M.,
de la CruzV. F.,
DaveyR. T.,
VenkatesanS.,
MossB.,
BiddisonW. E.,
FauciA. S.1990; Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. Journal of Immunology 145:127–135
KornfeldH.,
RiedelN.,
VigliantiG. A.,
HirschV.,
MullinsJ. I.1987; Cloning of HTLV-IV and its relation to simian and human immunodeficiency viruses. Nature, London 326:610–613
Langlade-DemoyenP.,
MichelF.,
HoffenbachA.,
VilmerE.,
DadaglioG.,
Garcia-PonsF.,
MayaudC.,
AutranB.,
Wain-HobsonS.,
PlataF.1988; Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. Journal of Immunology 141:1949–1957
LetvinN. L.,
DanielM. D.,
SehgalP. K.,
DesrosiersR. C.,
HuntR. D.,
WaldronL. M.,
MacKeyJ. J.,
SchmidtD. K.,
ChalifouxL. V.,
KingN. W.1985; Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71–73
LittauaR. A.,
OldstoneM. B. A.,
TakedaA.,
DebouckC.,
WongJ. T.,
TuazonC. U.,
MossB.,
KievitsF.,
EnnisF. A.1991; An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. Journal of Virology 65:4051–4056
MannhalterJ. W.,
PumM.,
WolfH. M.,
KupcuZ.,
BarrettN.,
DornerF.,
EderG.,
EiblM. M.1991; Immunization of chimpanzees with the HIV-1 glycoprotein gpl60 induces long-lasting T-cell memory. AIDS Research and Human Retroviruses 7:485–492
MillerM. D.,
LordC. I.,
StallardV.,
MazzaraG. P.,
LetvinN. L.1990; The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. Journal of Immunology 144:122–128
MillsK. H. G.,
KitchinP. A.,
MahonB. P.,
BarnardA. L.,
AdamsS. E.,
KingsmanS. M.,
KingsmanA. J.1990; HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. Journal of Immunology 144:16771683
NixonD. F.,
TownsendA. R. M.,
ElvinJ. G.,
RizzaC. R.,
GallweyJ.,
McMichaelA. J.1988; HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature, London 336:484–487
NixonD. F.,
HuetS.,
RothbardJ.,
KienyM.-P.,
DelchambreM.,
ThiriartC.,
RizzaC. R.,
GotchF. M.,
McMichaelA. J.1990; An HIV-1 and HIV-2 cross-reactive cytotoxic T cell epitope. AIDS 4:841–845
OrentasR. J.,
HildrethJ. E. K.,
ObahE.,
PolydefkisM.,
SmithG. E.,
ClementsM. L.,
SilicianoR. F.1990; Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gpl60 subunit vaccine. Science 248:1234–1237
ParhamP.,
BarnstableC. J.,
BodmerW. F.1979; Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C-antigens. Journal of Immunology 123:342–349
PutkonenP.,
BottigerB.,
WarstedtK.,
ThorstenssonR.,
AlbertJ.,
BiberfeldG.1989; Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. Journal of AIDS 2:366–373
PutkonenP.,
ThorstenssonR.,
WaltherL.,
AlbertJ.,
AkerblomL.,
GranquistO.,
WadellG.,
NorrbyE.,
BiberfeldG.1991; Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Research and Human Retroviruses 7:271–277
RabinH.,
NeubauerR.,
HopkinsR.,
DzhikidzeE.,
ShevtsovaZ.,
LapinB.1977; Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Intervirology 8:240–249
SamstagY.,
BaderA.,
MeuerS.1991; A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and NK cells. Journal of Immunology 147:788–794
SchrierR. D.,
GnannJ. W.,
LangloisA. J.,
ShriverK.,
NelsonJ. A.,
OldstoneM. B. A.1988; B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. Journal of Virology 62:2531–2536
SchrierR. D.,
GnannJ. W.,
LandesR.,
LockshinC.,
RichmanD.,
McCutchanA.,
KennedyC.,
OldstoneM. B. A.,
NelsonJ. A.1989; T cell recognition of HIV synthetic peptides in a natural infection. Journal of Immunology 142:1166–1176
SheppD. H.,
DaguillardF.,
MannD.,
QuinnanG. V.1988; Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens. AIDS 2:113–117
TakahashiH.,
TakeshitaT.,
MoreinB.,
PutneyS.,
GermainR. N.,
BerzofskyJ. A.1990; Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature, London 344:873–875
TsubotaH.,
LordC. I.,
WatkinsD. I.,
MorimotoC.,
LetvinN. L.1989; A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. Journal of Experimental Medicine 169:1421–1434
WahrenB.,
Morfeldt-ManssonL.,
BiberfeldG.,
MobergL.,
SonnerborgA.,
LjundmanP.,
WernerA.,
KurthR.,
GalloR.,
BolognesiD.1987; Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. Journal of Virology 61:2017–2023
WalkerB. D.,
FlexnerC.,
ParadisR. M.,
FullerT. C.,
HirschM. S.,
SchooleyR. T.,
MossB.1988; HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64–66
WalkerB. D.,
FlexnerC.,
Birch-LimbergerK.,
FisherL.,
ParadisT. J.,
AldoviniA.,
YoungR.,
MossB.,
SchooleyR. T.1989; Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A. 86:9514–9518
YamamotoH.,
MillerM. D.,
TsubotaH.,
WatkinsD. I.,
MazzaraG. P.,
StallardV.,
PanicaliD. L.,
AldoviniA.,
YoungR. A.,
LetvinN. L.1990a; Studies of cloned simian immunodeficiency virus-specific T lymphocytes. Journal of Immunology 144:3385–3391
ZarlingJ. M.,
EichbergJ. W.,
MoranP. A.,
McClureJ.,
SridharP.,
HuS.-L.1987; Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. Journal of Immunology 139:988–990
Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques